Metformin and Brivaracetam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Metformin (metformin hydrochloride) and Brivaracetam (brivaracetam). Common drug interactions include seizure among females and seizure among males.

The phase IV clinical study analyzes what interactions people have when they take Metformin and Brivaracetam. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Metformin?

Metformin has active ingredients of metformin hydrochloride. It is often used in diabetes. eHealthMe is studying from 465,354 Metformin users. Check the latest studies of Metformin.

What is Brivaracetam?

Brivaracetam has active ingredients of brivaracetam. eHealthMe is studying from 3,319 Brivaracetam users. Check the latest studies of Brivaracetam.



On Jul, 17, 2026

35 people who take Metformin and Brivaracetam together, and have interactions are studied.

Metformin and Brivaracetam drug interactions.

What are the common drug interactions of Metformin and Brivaracetam, by gender? *:

female:

  1. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  2. Fall
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Cough
  5. Facial paralysis (loss of function of face muscle)
  6. Immunodeficiency
  7. Nervousness
  8. Restlessness (not able to rest)
  9. Ascites (accumulation of fluid in the abdominal cavity)
  10. Asthenia (weakness)

male:

  1. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  2. Ankle fracture
  3. Sleep disorder
  4. Weight increased
  5. Head discomfort
  6. Oedema (fluid collection in tissue)
  7. Oesophageal disorder (disease of oesophagus)
  8. Spinal cord disorder (disease of spinal cord)
  9. Bradycardia (abnormally slow heart action)
  10. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)

What are the common drug interactions of Metformin and Brivaracetam, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Sudden unexplained death in epilepsy
  2. Fall
  3. Psoriasis (immune-mediated disease that affects the skin)
  4. Weight increased

30-39:

n/a

40-49:

  1. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  2. Ascites (accumulation of fluid in the abdominal cavity)
  3. Asthenia (weakness)
  4. Back pain
  5. Fall
  6. Fatigue (feeling of tiredness)
  7. Gallbladder enlargement
  8. Hepatic failure (liver failure)
  9. Hyperthyroidism (over activity of the thyroid gland)
  10. Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)

50-59:

  1. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Cough
  4. Facial paralysis (loss of function of face muscle)
  5. Immunodeficiency
  6. Nervousness
  7. Restlessness (not able to rest)
  8. Dry mouth
  9. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  10. Loss of consciousness

60+:

  1. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  2. Bradycardia (abnormally slow heart action)
  3. Somnolence (a state of near-sleep, a strong desire for sleep)
  4. Drug ineffective
  5. Emotional disorder
  6. Death
  7. Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
  8. Hypoaesthesia (reduced sense of touch or sensation)
  9. Umbilical hernia (an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the belly button)
  10. Cardiac arrest

What are the existing conditions these people have? *

  1. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 15 people, 42.86%
  2. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 9 people, 25.71%
  3. High Blood Pressure: 8 people, 22.86%
  4. Depression: 7 people, 20.00%
  5. High Blood Cholesterol: 6 people, 17.14%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 6 people, 17.14%
  7. Partial Seizures (seizures which affect only a part of the brain at onset): 4 people, 11.43%
  8. Stable Angina (a constant chest pain): 3 people, 8.57%
  9. Rickets (softening of bones): 3 people, 8.57%
  10. Back Pain: 3 people, 8.57%

* Approximation only. Some reports may have incomplete information.

Do you take Metformin and Brivaracetam?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Metformin and Brivaracetam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Metformin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Brivaracetam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Metformin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Brivaracetam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on metformin hydrochloride and brivaracetam (the active ingredients of Metformin and Brivaracetam, respectively), and Metformin and Brivaracetam (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: